Please, Desist RECIST Criteria in GIST, At Least in Me

Gastrointestinal stromal tumour (GIST) is an extraordinary and interesting disease both to physicians and patients. Every patient with GIST is a new experience for the medical oncologist [1–5]. The Response Evaluation Criteria in Solid Tumors (RECIST) are used in GIST. However, RECIST criteria show limitations in the response evaluation in imatinibtreated GIST [6, 7]. We report on an interesting patient with metastatic GIST in whom RECIST failed to show a response ….